CBD Life Sciences (OTCMKTS:CBDL) Stock Continues to Trade in a Range

October 22, 2021

Although CBD Life Sciences (OTCMKTS:CBDL) did make a significant announcement yesterday, it did not move the needle much with regards to its stock and it continued to trade within a range. However, it should be noted at the same time that a stock trading within a range can also manage to break out eventually and hence, the stock could be tracked. Market Action: On Thursday, CBDL stock remain unchanged at…

Read More >>

OTC Bounce List: CBDL, MWWC, BNOW, RNVA, TGHI

October 18, 2021

These stocks traded lower Friday and may bounce Monday. Keep them on your watchlist. Inspyr Therapeutics Inc (OTCMKTS:CBDL) was one of the major losers in the previous trading session as the stock slumped 25% to close at $0.0003. More than 751.93 million shares traded hands, compared to its average volume of 485.63 million shares. Last werk, CBD Life Sciences through its wholly owned subsidiary, LBC Bioscience Inc. announces that the…

Read More >>

CBD Life Sciences Inc. (OTCMKTS:CBDL) Stock in Focus After the Recent News

October 14, 2021

CBD Life Sciences Inc. (OTCMKTS:CBDL) on October 14, 2021, through the wholly owned subsidiary, LBC Bioscience Inc, announced that the firm has commenced on augmenting its rate of production of CBD-based products. This is in response to robust ecommerce demand after the launch on Amazon and new website launch with Alibaba happening soon. The company is keen on upgrading ecommerce platform as well as expanding on amplifying digital presence for…

Read More >>

Friday’s OTC Bounce List: CBDL, NECA, CYAP, PURA, BNOW, PDGO

October 8, 2021

These stocks traded lower Thursday and may bounce Friday. Keep them on your watchlist. CBD Life Sciences (OTCMKTS:CBDL) was one of the major losers in the previous trading session as the stock slumped 38% to close at $0.00025. More than 513.63 million shares traded hands, compared to its average volume of 445.20 million shares. CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic…

Read More >>

CBD Life Sciences (OTCMKTS:CBDL) Stock Picks Up Momentum: Now What?

August 31, 2021

CBD Life Sciences (OTCMKTS:CBDL) on August 30, 2021, announced applying for an Agriculture Hemp License in Arizona through its wholly-owned subsidiary, LBC Bioscience Inc. Analysts view this as a robust step towards growth as well as higher revenues as it will enable it to not just grow Hemp but also store it accordingly. President & CEO Lisa Nelson said that it is a fantastic opportunity for the firm to expand…

Read More >>

CBD Life Sciences (OTCMKTS:CBDL) Stock Moves Up 33%: But Why?

August 8, 2021

There were certain stocks which managed to come into sharp focus this past week and one of those was the CBD Life Sciences (OTCMKTS:CBDL) stock. The CBD Life Sciences stock ended the week on a strong note as it soared by as much as 33% on Friday and it seems that the rally in the stock was triggered by an announcement from the company last Wednesday. On August 4 the…

Read More >>

CBD Life Sciences Inc. (OTCMKTS: CBDL) Introduces Potent 3000MG Pain Relief Cream and Launches 2nd Location

July 22, 2021

CBD Life Sciences Inc. (OTCMKTS: CBDL) is up 25%. Recently the company announced an expansion of its product line through its subsidiary LBC Biosciences Inc. with the launch of a new pain relief cream. The company is working on a stronger 3000MG Pain Relief Cream Relative to its top-selling 2000MG cream. CND Life Sciences launches a more potent pain relief cream Lisa Nelson, the company’s CEO, said, “Whether you are…

Read More >>